Abstract
The recent characterization of the choline carrier of the malaria parasite and its role in the selective delivery of novel antimalarial drugs has reignited interest in parasite transporters as a drug-delivery strategy. In this article, we discuss these findings in relation to the wider context of developing a sustainable antimalarial-drug-development portfolio.
| Original language | English |
|---|---|
| Pages (from-to) | 299-301 |
| Number of pages | 3 |
| Journal | Trends In Parasitology |
| Volume | 21 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jul 2005 |